Columbia Partners L L C Investment Management cut its position in shares of Humana Inc (NYSE:HUM) by 11.9% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 17,861 shares of the insurance provider’s stock after selling 2,413 shares during the quarter. Columbia Partners L L C Investment Management’s holdings in Humana were worth $4,430,000 at the end of the most recent quarter.
A number of other large investors have also recently made changes to their positions in the business. Janus Henderson Group PLC increased its stake in Humana by 74.1% during the third quarter. Janus Henderson Group PLC now owns 2,729,248 shares of the insurance provider’s stock worth $664,921,000 after acquiring an additional 1,161,661 shares during the last quarter. Wells Fargo & Company MN grew its stake in shares of Humana by 11.4% in the fourth quarter. Wells Fargo & Company MN now owns 1,842,029 shares of the insurance provider’s stock valued at $456,951,000 after buying an additional 188,711 shares in the last quarter. Ameriprise Financial Inc. grew its stake in shares of Humana by 10.8% in the third quarter. Ameriprise Financial Inc. now owns 1,465,119 shares of the insurance provider’s stock valued at $356,960,000 after buying an additional 142,706 shares in the last quarter. Acadian Asset Management LLC grew its stake in shares of Humana by 3.0% in the fourth quarter. Acadian Asset Management LLC now owns 1,043,303 shares of the insurance provider’s stock valued at $258,809,000 after buying an additional 30,812 shares in the last quarter. Finally, Capital International Investors grew its stake in shares of Humana by 8.8% in the third quarter. Capital International Investors now owns 760,500 shares of the insurance provider’s stock valued at $185,281,000 after buying an additional 61,500 shares in the last quarter. Institutional investors own 97.68% of the company’s stock.
Shares of Humana Inc (HUM) opened at $267.81 on Friday. Humana Inc has a 12 month low of $203.48 and a 12 month high of $293.35. The company has a current ratio of 1.85, a quick ratio of 1.61 and a debt-to-equity ratio of 0.48. The firm has a market capitalization of $36,676.35, a P/E ratio of 22.79, a price-to-earnings-growth ratio of 1.44 and a beta of 0.93.
Humana (NYSE:HUM) last issued its quarterly earnings data on Wednesday, February 7th. The insurance provider reported $2.06 earnings per share for the quarter, beating analysts’ consensus estimates of $2.00 by $0.06. Humana had a return on equity of 16.13% and a net margin of 4.55%. The firm had revenue of $13.19 billion during the quarter, compared to analyst estimates of $13.14 billion. During the same quarter last year, the firm earned $2.34 EPS. Humana’s quarterly revenue was up 2.4% on a year-over-year basis. equities research analysts forecast that Humana Inc will post 13.86 earnings per share for the current year.
Humana declared that its board has approved a share repurchase program on Thursday, December 14th that permits the company to buyback $3.00 billion in outstanding shares. This buyback authorization permits the insurance provider to buy shares of its stock through open market purchases. Shares buyback programs are generally an indication that the company’s leadership believes its stock is undervalued.
The firm also recently disclosed a quarterly dividend, which will be paid on Friday, April 27th. Shareholders of record on Friday, March 30th will be paid a dividend of $0.50 per share. This represents a $2.00 dividend on an annualized basis and a yield of 0.75%. The ex-dividend date of this dividend is Wednesday, March 28th. This is a positive change from Humana’s previous quarterly dividend of $0.40. Humana’s dividend payout ratio (DPR) is 9.59%.
In other Humana news, VP Timothy S. Huval sold 1,382 shares of the stock in a transaction that occurred on Tuesday, December 19th. The stock was sold at an average price of $246.04, for a total transaction of $340,027.28. Following the transaction, the vice president now owns 11,557 shares of the company’s stock, valued at approximately $2,843,484.28. The transaction was disclosed in a document filed with the SEC, which is available at this link. Also, SVP Brian P. Leclaire sold 1,679 shares of the stock in a transaction that occurred on Thursday, December 21st. The stock was sold at an average price of $245.97, for a total value of $412,983.63. Following the transaction, the senior vice president now directly owns 9,888 shares in the company, valued at approximately $2,432,151.36. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 10,115 shares of company stock valued at $2,501,627. 0.80% of the stock is owned by insiders.
A number of equities research analysts have recently issued reports on HUM shares. Credit Suisse Group started coverage on Humana in a research note on Thursday, November 2nd. They issued a “neutral” rating and a $256.00 target price for the company. Royal Bank of Canada reiterated a “sector perform” rating and issued a $242.00 target price (down previously from $245.00) on shares of Humana in a research note on Thursday, November 9th. Morgan Stanley lowered their target price on Humana from $276.00 to $270.00 and set an “overweight” rating for the company in a research note on Thursday, November 9th. BMO Capital Markets increased their target price on Humana from $290.00 to $300.00 and gave the company an “outperform” rating in a research note on Friday, November 10th. Finally, Cantor Fitzgerald reiterated a “hold” rating and issued a $230.00 target price on shares of Humana in a research note on Tuesday, December 5th. Seven analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the stock. The company currently has a consensus rating of “Buy” and a consensus price target of $270.47.
TRADEMARK VIOLATION WARNING: “Humana Inc (HUM) Shares Sold by Columbia Partners L L C Investment Management” was posted by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are reading this piece of content on another site, it was stolen and reposted in violation of United States and international copyright & trademark law. The original version of this piece of content can be accessed at https://www.dispatchtribunal.com/2018/02/23/humana-inc-hum-shares-sold-by-columbia-partners-l-l-c-investment-management.html.
Humana Company Profile
Humana Inc is a health and well-being company. The Company’s segments include Retail, Group and Specialty, Healthcare Services and Individual Commercial. The Retail segment consists of Medicare benefits, as well as individual commercial fully insured medical and specialty health insurance benefits, including dental, vision, and other supplemental health and financial protection products.
Want to see what other hedge funds are holding HUM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Humana Inc (NYSE:HUM).
Receive News & Ratings for Humana Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana and related companies with MarketBeat.com's FREE daily email newsletter.